Diagnosis, Impact, and Management of Focal Hyperhidrosis: Treatment Review Including Botulinum Toxin Therapy

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 1, 2007, Pages 17-30

  Cohen, Joel L ^a   Cohen, Goldie ^b   Solish, Nowell ^c   Murray, Christian A ^c  

^a AboutSkin Dermatology and DermSurgery PC   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ALUMINUM CHLORIDE; BELLADONNA ALKALOID; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIAZEPAM; DILTIAZEM; EMLA; FORMALDEHYDE; GABAPENTIN; GLUTARALDEHYDE; HYALURONIDASE; INDOMETACIN; LOCAL ANESTHETIC AGENT; PHENOXYBENZAMINE; PHENTOLAMINE; PLACEBO; PROPRANOLOL;

ANXIETY; ASTHENIA; AXILLA; BLURRED VISION; BURNING SENSATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONTACT SENSITIZATION; DIPLOPIA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRY THROAT; DYSPHAGIA; FACE; FOOT SOLE; HAND PALM; HUMAN; HYPERHIDROSIS; INCIDENCE; INDIGESTION; IONTOPHORESIS; LACRIMATION; LOW DRUG DOSE; MUSCLE WEAKNESS; NONHUMAN; PSYCHOLOGICAL ASPECT; PTOSIS; REVIEW; SALIVATION; SIDE EFFECT; SKIN DISCOLORATION; SKIN IRRITATION; SOCIAL ASPECT; SWEATING; SYMPATHECTOMY; TACHYCARDIA; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; URINE RETENTION; XEROSTOMIA;

ALDEHYDES; ALUMINUM COMPOUNDS; ANESTHETICS; BOTULINUM TOXIN TYPE A; CHLORIDES; CHOLINERGIC ANTAGONISTS; COMPLEMENTARY THERAPIES; HUMANS; HYPERHIDROSIS; IONTOPHORESIS; NEUROMUSCULAR AGENTS; SYMPATHECTOMY;

EID: 33847047143     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2006.10.002     Document Type: Review

References (117)

1. Sato K., Kang W.H., and Saga K.T. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol 20 (1989) 537-563
2. Heckmann M., Ceballos-Baumann A.O., and Plewig G. Botulinum toxin A for axillary hyperhidrosis. N Engl J Med 344 (2001) 488-493
3. Hornberger J., Grimes K., Naumann M., et al. Recognition, diagnosis, and treatment of primary focal hyperhydrosis. J Am Acad Dermatol 51 (2004) 274-286
4. Adar R., Kurchin A., Zweig A., et al. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg 186 (1977) 34-41
5. Stolman L.P. Treatment of hyperhidrosis. Dermatol Clin 16 (1998) 863-867
6. Strutton D.R., Kowalski J.W., Glaser D.A., et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51 (2004) 241-248
7. Amir M., Arish A., Weinstein Y., et al. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci 37 (2000) 25-31
8. Cina C.S., and Clase C.M. The Illness Intrusiveness Rating Scale: a measure of severity in individuals with hyperhidrosis. Qual Life Res 8 (1999) 693-698
9. Swartling C., Naver H., and Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 8 (2001) 247-252
10. Tan S.R., and Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg 28 (2002) 495-499
11. Naumann M., Hamm H., and Lowe N. Effect of botulinum toxin A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 147 (2002) 1218-1226
12. Campanati A., Penna L., Guzzo T., et al. A quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. Clin Ther 25 1 (2003) 298-308
13. Hashmonai M., Kopelman D., and Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today 30 (2000) 211-218
14. Lere B., Jacobowitz J., and Wahaba A. Personality features in essential hyperhidrosis. Int J Psychiatry Med 10 (1981) 59-67
15. Atkins J.L., and Butler P.E.M. Hyperhidrosis: a review of current management. Plast Reconstr Surg 110 (2002) 222-228
16. Naumann M., Hamm H., Kinkelin I., et al. Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions. Eur J Neurol 6 (1999) S111-S115
17. Kreydon O., and Scheidegger E. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol 22 (2004) 40-44
18. Sato K., Kang W.T., and Saga K.T. Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol 20 (1989) 713-726
19. Ro K.M., Cantor R.M., Lange K.L., et al. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg 35 (2002) 382-386
20. Uno H. Sympathetic innervation of sweat glands and piloerector muscle of macaques and human beings. J Invest Dermatol 69 (1977) 112-117
21. Manca D., Valls-Sole J., and Callejas M.A. Excitability recovery curve of the sympathetic skin response in healthy volunteers and patients with palmer hyperhidrosis. Clin Neurophysiol 111 (2000) 1767-1770
22. Freeman R., Waldorf H.A., and Dover J.S. Autonomic neurodermatology (part II): disorders of sweating and flushing. Semin Neurol 12 (1992) 394-407
23. Glogau R.G. Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg 24 (1998) 817-819
24. Iwase S., Ikelda T., Kitazawa H., et al. Altered response in cutaneous sympathetic outflow to mental and thermal stimuli in primary palmoplantar hyperhidrosis. J Auton Nerv Syst 64 (1997) 65-73
25. Mamose T., Kunimoto M., Nishikawa J., et al. N-isopropyl I-123 p-iodoamphetamine brain scans with single photon emission computed tomography: mental sweating and EEG abnormality. Radiat Med 4 (1986) 46-50
26. Shih C.J., Wu J.J., and Lin M.T. Autonomic dysfunction in palmar hyperhidrosis. J Auton Nerv Syst 8 (1983) 33-43
27. Birner P., Heinzl H., Schindl M., et al. Cardiac autonomic function in patients suffering from primary focal hyperhidrosis. Eur Neurol 44 (2000) 112-116
28. Kaya D., Karaca S., Barutcu I., et al. Heart rate variability in patients with essential hyperhidrosis: dynamic influence of sympathetic and parasympathetic maneuvers. Ann Noninvasive Electrocardiol 10 1 (2005) 1-6
29. Kreyden O.P., Boni R., and Burg G. Hyperhidrosis and botulinum toxin in dermatology. Curr Probl Dermatol 30 (2002) 10-45
30. Kreyden O.P. Rare forms of hyperhidrosis. Curr Probl Dermatol 30 (2002) 178-187
31. Leung A.K.C., Chan P.Y.H., and Choi M.C.K. Hyperhidrosis. Int J Dermatol 38 (1999) 561-567
32. Hund M., Kinkelin I., Naumann M., et al. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol 138 (2002) 539-541
33. Minor V. Ein neues Verfahren zu der klinischen Unterschung der Schweibabsonderung. Dtsch Z Nervenheilkd 101 (1927) 302-308
34. Weber A., Heger R., Sinkgraven M., et al. Psychosocial aspects of patients with focal hyperhidrosis: marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol 114 (2005) 343-345
35. Finlay A.Y., and Khan G.K. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19 (1994) 210-216
36. Qualtrale R.P., Coble D.W., Stoner K.L., et al. The mechanism of antiperspirant action by aluminum salts. II. Histologic observations of human eccrine sweat glands inhibited by aluminum chlorohydrate. J Soc Cosmet Chem 32 (1981) 107-136
37. Holzle E., and Braun-Falco O. Structural alterations of axillary eccrine glands in hyperhidrosis following long-term treatment with aluminum chloride hexahydrate. Br J Dermatol 110 (1984) 399-403
38. Gordon B.I., and Maibach H.I. Eccrine anhidrosis due to glutaraldehyde, formaldehyde and iontophoresis. J Invest Dermatol 53 (1969) 436-439
39. Sato K., and Dobson R.L. Mechanism of the antiperspirant effect of topical glutaraldehyde. Arch Dermatol 100 (1969) 564-569
40. Holzle E. Topical pharmacologic treatment (in hyperhidrosis and botulinum toxin in dermatology). Curr Probl Dermatol 30 (2002) 30-43
41. Juhlin L., Evers H., and Broberg F. Inhibition of hyperhidrosis by application of a local anesthetic composition. Acta Derm Venereol 59 (1979) 556-559
42. MacMillan F., Reller H., and Synder F. The antiperspirant action of topically applied anticholinergics. J Invest Dermatol 43 (1964) 363-377
43. Agren-Johnson S., and Magnusson B. Sensitization to propantheline bromide, trichlorocarbanilide and propylene glycol in antiperspirant. Contact Dermatitis 2 (1976) 79-80
44. Hays L.L., Novack A.J., and Worsham J.C. The Frey syndrome: a simple, effective treatment. Otolaryngol Head Neck Surg 90 (1982) 419-425
45. Seukeran D.C., and Higet A.S. The use of topical glycopyrrolate in the treatment of hyperhidrosis. Clin Exp Dermatol 23 (1998) 204-205
46. Luh J., and Blackwell T. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate. South Med J 95 7 (2002) 756-758
47. Urman J.D., and Bobrove A.M. Diabetic gustatory sweating successfully treated with topical glycopyrrolate: a report of a case and review of the literature. Arch Intern Med 159 (1999) 877-878
48. Dolianitis C., Scarff C.E., Kelly J., et al. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Aust J Dermatol 45 4 (2004) 208-212
49. Sato K., Timm D.E., Sato F., et al. Generation and transit pathway of H+ is critical for inhibition of palmar sweating by iontophoresis in water. J Appl Physiol 75 (1993) 2258-2264
50. Sloan J.B., and Soltani K. Iontophoresis is dermatology. J Am Acad Dermatol 15 (1986) 671-684
51. Levit F. Simple device for the treatment of hyperhidrosis by iontophoresis. Arch Dermatol 98 (1968) 505-507
52. Reinauer S., Neusser A., Schauf G., et al. Iontophoresis with alternation current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol 129 (1993) 166-169
53. Karakoc Y., Aydemir E.H., Kalkan M.T., et al. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int J Dermatol 41 9 (2002) 602-605
54. Tkach J.R. Indomethacin treatment of generalized hyperhidrosis. J Am Acad Dermatol 6 (1982) 545
55. Adams B.B., Vargus-Adams J.N., Franz D.N., et al. Hyperhidrosis in pediatric spinal cord injury: a case report and gabapentin therapy. J Am Acad Dermatol 46 (2002) 444-446
56. Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry 56 (1995) 35
57. Bar L.H., and Kuypers B.R. Behavior therapy in dermatologic practice. Br J Dermatol 88 (1973) 591
58. Duller P., and Gentry W.D. Use of biofeedback in treating chronic hyperhidrosis: a preliminary report. Br J Dermatol 103 (1980) 143-146
59. Shenefelt P.D. Hypnosis in dermatology. Arch Dermatol 136 (2000) 393-399
60. Hurley H.J., and Shelley W.B. Simple surgical approach to the management of axillary hyperhidrosis. JAMA 186 (1963) 109
61. Wang H.J., Cheng T.Y., and Chen T.M. Surgical management of axillary bromhidrosis: a modified Skoog procedure by an axillary bipedicle flap approach. Plast Reconstr Surg 98 (1996) 524-529
62. Wu W.H. Surgical treatment of axillary osmidrosis: an analysis of 343 cases. Plast Reconstr Surg 94 (1994) 288-294
63. 2 laser and subcutaneous tissue remover. Dermatol Surg 25 (1999) 875-879
64. Jemec B. Abrasio axillae in hyperhidrosis. Scand J Plast Reconstr Surg 9 (1975) 44
65. Tsai R.Y., and Lin J.Y. Experience of tumescent liposuction in the treatment of osmidrosis. Dermatol Surg 27 5 (2001) 446-448
66. Lillis P.J., and Coleman W.P. Liposuction for treatment of axillary hyperhidrosis. Dermatol Clin 8 (1990) 479-482
67. Shenaq S.M., and Spira M. Treatment of bilateral axillary hyperhidrosis by suction-assisted lipolysis technique. Ann Plast Surg 19 (1987) 548-551
68. Dondelinger R.F., and Kurdziel J.C. Percutaneous phenol block of the upper thoracic sympathetic chain with computed tomography guidance: a new technique. Acta Radiol 28 (1987) 511-515
69. Kao M.C., Chern S.H., Cheng L.C., et al. Minimally invasive surgery: video endoscopic thoracic sympathectomy for palmar hyperhidrosis. Ann Acad Med Singapore 25 (1996) 673-678
70. Chiou T.S. Chronological changes of postsympathectomy compensatory hyperhidrosis and recurrent sweating in patients with palmar hyperhidrosis. J Neurosurg Spine 2 2 (2005) 151-154
71. Ling T.S., and Fang H.Y. Thoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis with emphasis on preoperative management. Surg Neurol 52 (1999) 453-457
72. Lin T.S., Wang N.P., and Huang L.C. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Invest 2 (2001) 377-385
73. Han P.P., Gottfried O.N., Kenny K.J., et al. Biportal thoracic sympathectomy: surgical techniques and clinical results for the treatment of hyperhidrosis. Neurosurgery 50 (2002) 306-311
74. Rex L.O., Drott C., Claes G., et al. The Boras experience of endoscopic sympathectomy for the treatment of palmar, axillary, facial hyperhydrosis and facial blushing and palmar plantar hyperhidrosis. Eur J Surg Suppl 580 (1998) 23-26
75. Sihoe A.D., Cheung C.S., Lai H.K., et al. Incidence of chest wall paresthesia after needlescopic video-assisted thoracic surgery for palmar hyperhidrosis. Eur J Cardiothorac Surg 27 2 (2005) 313-319
76. Duarte J.B., and Kux P. Improvements in video endoscopic sympathectomy for the treatment of palmar, axillary, facial, and palmar plantar hyperhidrosis. Eur J Surg Suppl 580 (1998) 9-11
77. Dumont P., Denoyer A., and Robin P. Long-term results of thoracoscopic sympathectomy of hyperhidrosis. Ann Thorac Surg 78 5 (2004) 1801-1807
78. Ambache N. A further survey of the action of clostridium botulinum toxin upon different types of autonomic nerve fiber. J Physiol 113 (1951) 1-17
79. Bushara K.O., and Park D.M. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry 57 (1994) 1437-1438
80. Bushara K.O., Park D.M., and Jones J.C. Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 21 (1996) 276-278
81. Odderson I.R. Axillary hyperhidrosis: treatment with botulinum toxin A. Arch Phys Med Rehabil 79 (1998) 350-352
82. Schnider P., Binder M., Kittler H., et al. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol 140 (1999) 677-680
83. Naumann M.K., and Lowe N.J. Botulinum toxin A in treatment of bilateral primary axillary hyperhidrosis: a randomized, parallel group, double blind, placebo controlled trial. BMJ 323 (2001) 596-599
84. Lowe N.J., Yamaushi P.S., Lask G.P., et al. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 28 9 (2002) 822-827
85. Sinclair M.T., Russell W., Toosey R.W., et al. Prospective double blind randomized controlled trial of botulinum toxin A in axillary hyperhidrosis. Br J Surg 88 (2001) 80
86. Baumann L., and Halem M. Botulinum toxin B and management of hyperhidrosis. Clin Dermatol 22 (2004) 60-65
87. Nelson L., Bachoo P., and Holmes J. Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg 58 (2005) 228-232
88. Glaser DA, Solish N, Naumann MK, et al. [Poster abstract]. Botulinum toxin type A improves occupational impairment associated with primary axillary hyperhidrosis and results in high levels of satisfaction with treatment. Presented at the Summer Meeting of the American Academy of Dermatology. New York, July, 2004.
89. Glaser DA, Kowalski JW, Weng Y, et al. [Poster abstract]. Effect of repeated botulinum toxin type A treatment on quality of life and functioning in patients with severe primary axillary hyperhidrosis: results from 2 years longitudinal data. Presented at the Summer Meeting of the American Academy of Dermatology. Chicago, July, 2005.
90. Wollina U., Karamfilov M.D., and Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol 29 (2002) 533-538
91. Glaser A, et al. [Abstract 195]. Presented at the American Academy of Dermatology 62nd Annual Meeting. Washington, DC, February 2004.
92. Goodman G. Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg 29 (2003) 533-538
93. Heckman M., Teichman B., Pause B.M., et al. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A. Arch Dermatol 139 (2003) 57-59
94. Lapiere J.C., Hirsh A., Gordon K.B., et al. Botulinum toxin type A for the treatment of axillary Hailey-Hailey disease. Dermatol Surg 26 (2000) 371-374
95. Schnider P., Binder M., Berger T., et al. Botulinum toxin injection in focal hyperhidrosis. Br J Dermatol 131 (1996) 1151-1165
96. Schnider P., Binder M., Berger T., et al. Double-blind trial of botulinum A toxin in the treatment of focal hyperhidrosis of the palms. Br J Dermatol 136 (1997) 548-552
97. Saadia D., Voustianiouk A., Ang A.K., et al. Botulinum toxin type A in primary palmar hyperhidrosis. Neurology 57 (2001) 2095-2099
98. Wollina U., and Karamfilov T. Botulinum toxin A for palmar hyperhidrosis. J Eur Acad Dermatol Venereol 15 6 (2001) 555-558
99. Solomon B.A., and Hayman R. Botulinum toxin A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 42 6 (2000) 1026-1029
100. De-Almeida A.R., Kadunc B.V., and De Liveira E.M. Improving botulinum toxin therapy for palmar hyperhidrosis: wrist block and technical considerations. Dermatol Surg 27 (2001) 34-36
101. Blaheta H.J., Vollert B., Zuder D., et al. Intravenous regional anesthesia (Bier's block) for botulinum toxin therapy of palmar hyperhidrosis is safe and effective. Dermatol Surg 28 8 (2002) 666-671
102. Swartlng C., Farnstand C., Abt G., et al. Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study. Eur J Neurol 8 5 (2001) 451-456
103. Baumann L.S., and Halem M.L. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol 139 2 (2003) 226-227
104. Tugnoli V., et al. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol 147 4 (2002) 808-809
105. Naumann M., et al. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 134 3 (1998) 301-304
106. Sevin S., Dogu O., and Kaleagasi H. Botulinum toxin-A therapy for palmar and plantar hyperhidrosis. Acta Neurol Belg 102 4 (2002) 167-170
107. Vodoud-Seyedi J., Simonart T., and Heenn N. Treatment of plantar hyperhidrosis with dermojet injections of botulinum toxin. Dermatology 201 2 (2000) 179
108. Kinkelin I., Hund M., Naumann M., et al. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol 143 4 (2000) 824-827
109. Tugnoli V., et al. The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A. Clin Auton Res 12 (2002) 174-178
110. Naumann M., Zellner M., Tokya T.V., et al. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 42 (1997) 973-975
111. Laccourreye O., et al. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg 125 3 (1999) 283-286
112. Kyrmizakis D.E., Pangalos A., Papadakis C.E., et al. J Oral Maxillofac Surg 62 (2004) 840-844
113. Lam D.G., and Choudhary S. Use of a grid to simplify botulinum toxin injection for axillary hyperhidrosis. Plast Reconstr Surg 112 6 (2003) 1741-1742
114. Becton-Dickinson, Franklin Lakes, New Jersey.
115. Vadoud-Seyedi J. Int J Dermatol 43 (2004) 969-971
116. Kavanaugh G.M., Oh C., and Shams K. Br J Dermatol 151 (2004) 1093-1095
117. Krogstad A., Skymne A., Pegenius G., et al. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis. Br J Dermatol 152 (2005) 329-333